Musheng Y. Zeng
651 Dongfeng East Road
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 118 publications
Epstein-Barr Virus-Mediated Tumorigenesis in Nasopharyngeal Carcinoma.
Journal: Current topics in microbiology and immunology
Published: August 26, 2026
Correction: Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer.
Journal: Molecular cancer
Published: July 03, 2026
Author Correction: A broadly protective antibody targeting gammaherpesvirus gB.
Journal: Nature
Published: June 09, 2026
A protective human antibody reveals a quaternary epitope on the Epstein-Barr virus fusion apparatus.
A protective human antibody reveals a quaternary epitope on the Epstein-Barr virus fusion apparatus.
Journal: Cell chemical biology
Published: September 29, 2025
Author Correction: Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibition.
Journal: Nature communications
Published: September 18, 2025
Apo10 and TKTL1 in blood macrophages as non-invasive biomarkers for early detection of cervical cancer.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: May 30, 2025
Targeting EBV gp42 for nasopharyngeal carcinoma prevention.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 29, 2025
Long Non-Coding RNA IGFRIL Couples with PTBP1 to Destabilize IGFBP3 mRNA to Promote the IGF1R-AKT-mTOR Axis and Hepatocellular Carcinoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 28, 2025
A potent human neutralizing antibody targeting the receptor-binding site in the glycoprotein gp350 of Epstein-Barr virus.
Journal: Science China. Life sciences
Published: April 04, 2025
Chemotherapy-induced CA-repeat DNA fragments in breast cancer trigger antitumor immune responses.
Journal: Nature immunology
Published: January 25, 2025
Last Updated: 09/26/2026